According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are ยฃ13.84 Billion. In 2023 the company made an earning of ยฃ3.24 Billion a decrease over its 2022 earnings that were of ยฃ3.76 Billion. The earnings displayed on this page is the company's Pretax Income.